Simone Biagini - Publications

TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.

Journal: Blood

Published: May 30, 2023

αβT- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes.

Journal: Haematologica

Published: January 20, 2022

Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.

Journal: Frontiers in immunology

Published: February 19, 2020

Preservation of Antigen-Specific Functions of αβ T Cells and B Cells Removed from Hematopoietic Stem Cell Transplants Suggests Their Use As an Alternative Cell Source for Advanced Manipulation and Adoptive Immunotherapy.

Journal: Frontiers in immunology

Published: October 20, 2016

Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: June 04, 2016

Immunoselection techniques in hematopoietic stem cell transplantation.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: May 23, 2016

Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress.

Journal: Oncotarget

Published: May 17, 2016

Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia.

Journal: British journal of haematology

Published: February 03, 2015

Cysteamine treatment restores the in vitro ability to differentiate along the osteoblastic lineage of mesenchymal stromal cells isolated from bone marrow of a cystinotic patient.

Journal: Journal of translational medicine

Published: October 27, 2014

Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.

Journal: Stem cells and development

Published: July 19, 2014

Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro.

Journal: Stem cells and development

Published: June 18, 2014

Human mesenchymal stromal cells primed with paclitaxel, apart from displaying anti-tumor activity, maintain their immune regulatory functions in vitro.

Journal: Cytotherapy

Published: November 22, 2013